This message is being sent as part of ISOPP’s Survey Distribution Service on behalf of the University College London and University College London NHS Foundation Trust and is not an endorsement or recommendation of the survey or message content.  

COVID-19 and Systemic Anti-cancer Therapy Survey

On behalf of the University College London and University College London NHS Foundation Trust

In light of Covid-19 there have been some mitigation strategies implemented either nationally or within local hospitals. As a group of clinical academics based at University College London we are interested in understanding the approach your institution has taken regarding the care of cancer patients, in terms of the policies/practice regulations which have been issued and how these have been translated into practice. We believe you can help shed light on this.
 
By completing the online questionnaire, you will help us reveal variations in the global response to COVID-19 within the context of cancer care. Such findings could prove vital in informing the revision of care for cancer patients throughout the duration of the pandemic. Furthermore, this would bear importance in informing policy and practice of future virus outbreaks should they occur.
 
The survey is developed by an international interdisciplinary team with researchers from the Rapid Research, Evaluation and Appraisal Lab (RREAL), University College London and University College London NHS Foundation Trust. To obtain more information about this collaboration please contact Pinkie Chambers (p.chambers@ucl.ac.uk). 
 
The average time for completion of this survey is 10 minutes and we would also appreciate any wider distribution to other professional groups within your institution.

English: 
https://opinio.ucl.ac.uk/s?s=67363  
 
Spanish: 
https://opinio.ucl.ac.uk/s?s=67363&lang=es
 
French: 
https://opinio.ucl.ac.uk/s?s=67363&lang=fr